Anti-depressant may cut Covid hospitalisation risk

A low cost drug used commonly to treat depression and obsessive compulsive disorder has been found useful in reducing by a third the risk of prolonged hospitalisation of Covid-19 patients. A study published in The Lancet Global Health named this drug as Fluvoxamine, which was given to 741 Covid patients in Brazil as part of a randomised trial to investigate the efficacy of eight repurposed treatments for the infection.

from Delhi News: Latest Delhi News Headlines & Live Updates from Delhi - Times of India https://ift.tt/3CsjuUT